Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women.

Q2 Medicine Infectious Diseases in Obstetrics and Gynecology Pub Date : 2018-10-16 eCollection Date: 2018-01-01 DOI:10.1155/2018/4049212
Leilah Zahedi-Spung, Marisa Young, Lisa B Haddad, Martina L Badell
{"title":"Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women.","authors":"Leilah Zahedi-Spung,&nbsp;Marisa Young,&nbsp;Lisa B Haddad,&nbsp;Martina L Badell","doi":"10.1155/2018/4049212","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Although rare, perinatal HIV transmission still occurs in the United States and most transmissions are preventable. We aim to identify patient barriers to antiretroviral therapy (ART) adherence during pregnancy and assess patient understanding of perinatal transmission.</p><p><strong>Methods: </strong>This cross-sectional survey recruited HIV positive postpartum women at a large safety net hospital in Atlanta, Georgia, between January 2016 and February 2018. Survey questions included demographic characteristics, HIV history, knowledge of perinatal transmission, and ART adherence. Perinatal and HIV outcomes were assessed using chart abstraction.</p><p><strong>Results: </strong>Of the 70 HIV infected postpartum women delivered at a large safety net hospital in Atlanta, GA, 45 women were eligible and consented to participate. Participating women were aged 18 to 40 years with an average age of 29 years old, 93% of participants were African-American, and 68% had ≥3 pregnancies. The majority of participants (75%) reported daily ART adherence. \"Forgetting\" was the most frequent reason for missing pills (57%). Thirteen women had a detectable viral load at the time of delivery and nine of those women had a viral load greater than 1000 copies/mL. Approximately 85% of women who correctly stated ART medications decrease perinatal transmission risk reported daily adherence compared with 50% of women without that knowledge (OR 5.6, 95% CI 1.17, 26.7). Almost half of women (40%) either did not know or believed a vaginal delivery, regardless of viral load, would increase their risk of perinatal transmission.</p><p><strong>Conclusion: </strong>Overall, women who were diagnosed with HIV during the current pregnancy, those with planned pregnancies, and those who were on medications prior to pregnancy were more likely to report daily ART adherence. Detectable viral load at delivery is the greatest risk factor for perinatal transmission; therefore strategies to increase ART adherence are needed.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":" ","pages":"4049212"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/4049212","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases in Obstetrics and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2018/4049212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 7

Abstract

Introduction: Although rare, perinatal HIV transmission still occurs in the United States and most transmissions are preventable. We aim to identify patient barriers to antiretroviral therapy (ART) adherence during pregnancy and assess patient understanding of perinatal transmission.

Methods: This cross-sectional survey recruited HIV positive postpartum women at a large safety net hospital in Atlanta, Georgia, between January 2016 and February 2018. Survey questions included demographic characteristics, HIV history, knowledge of perinatal transmission, and ART adherence. Perinatal and HIV outcomes were assessed using chart abstraction.

Results: Of the 70 HIV infected postpartum women delivered at a large safety net hospital in Atlanta, GA, 45 women were eligible and consented to participate. Participating women were aged 18 to 40 years with an average age of 29 years old, 93% of participants were African-American, and 68% had ≥3 pregnancies. The majority of participants (75%) reported daily ART adherence. "Forgetting" was the most frequent reason for missing pills (57%). Thirteen women had a detectable viral load at the time of delivery and nine of those women had a viral load greater than 1000 copies/mL. Approximately 85% of women who correctly stated ART medications decrease perinatal transmission risk reported daily adherence compared with 50% of women without that knowledge (OR 5.6, 95% CI 1.17, 26.7). Almost half of women (40%) either did not know or believed a vaginal delivery, regardless of viral load, would increase their risk of perinatal transmission.

Conclusion: Overall, women who were diagnosed with HIV during the current pregnancy, those with planned pregnancies, and those who were on medications prior to pregnancy were more likely to report daily ART adherence. Detectable viral load at delivery is the greatest risk factor for perinatal transmission; therefore strategies to increase ART adherence are needed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
感染艾滋病毒的孕妇产前坚持服药的障碍。
简介:虽然罕见,围产期艾滋病毒传播仍然发生在美国,大多数传播是可以预防的。我们的目的是确定患者在怀孕期间坚持抗逆转录病毒治疗(ART)的障碍,并评估患者对围产期传播的理解。方法:本横断面调查于2016年1月至2018年2月在佐治亚州亚特兰大市的一家大型安全网医院招募HIV阳性产后妇女。调查问题包括人口统计学特征、艾滋病毒史、围产期传播知识和抗逆转录病毒治疗依从性。围产期和艾滋病毒结局采用图表抽象评估。结果:在亚特兰大一家大型安全网医院分娩的70名感染HIV的产后妇女中,45名妇女符合条件并同意参加。参与研究的女性年龄在18至40岁之间,平均年龄29岁,93%的参与者是非裔美国人,68%的参与者怀孕3次以上。大多数参与者(75%)报告每天坚持抗逆转录病毒治疗。“忘记”是丢失药片最常见的原因(57%)。13名妇女在分娩时检测到病毒载量,其中9名妇女的病毒载量大于1000拷贝/毫升。在正确陈述抗逆转录病毒药物可降低围产期传播风险的妇女中,约85%的人报告每天坚持服用抗逆转录病毒药物,而不了解这一知识的妇女中,只有50%的人报告每天坚持服用抗逆转录病毒药物(OR 5.6, 95% CI 1.17, 26.7)。几乎一半的妇女(40%)不知道或不相信阴道分娩,无论病毒载量如何,都会增加围产期传播的风险。结论:总的来说,在怀孕期间被诊断出感染艾滋病毒的妇女、计划怀孕的妇女和怀孕前接受药物治疗的妇女更有可能报告每天坚持抗逆转录病毒治疗。分娩时可检测到的病毒载量是围产期传播的最大危险因素;因此,需要提高抗逆转录病毒治疗依从性的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Infectious Diseases in Obstetrics and Gynecology
Infectious Diseases in Obstetrics and Gynecology Medicine-Obstetrics and Gynecology
CiteScore
3.80
自引率
0.00%
发文量
17
审稿时长
12 weeks
期刊介绍: Infectious Diseases in Obstetrics and Gynecology aims to disseminate new and important information to clinicians and other health care providers, scientists, and researchers involved in the study or treatment of infectious diseases, especially those affecting the female patient. Its ultimate aim is to advance knowledge and encourage research, thereby improving the prevention or diagnosis and treatment of patients affected by such diseases.
期刊最新文献
Intrapartum and 30-Day Postpartum Complications in Patients With Antenatal COVID-19 Infection: A Retrospective Cohort Study. CER818: A Highly Specific and Sensitive HPV L1 High-Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions. Determinants of Cervical Cancer Screening among Female Health Professionals in Harar Town, Eastern Ethiopia: A Cross-Sectional Study. Seroinfection of Antibodies to Toxoplasma gondii, Parvovirus B19, Treponema pallidum, and HIV in a Pregnant Attending a Medical Center in Northern Peru. Seroprevalence of Toxocara spp. in Pregnant Women: A Systematic Review and Meta-Analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1